Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M7XS
|
|||
| Former ID |
DAP001300
|
|||
| Drug Name |
Antithymocyte globulin
|
|||
| Synonyms |
Atgam (TN); Thymoglobulin (TN)
Click to Show/Hide
|
|||
| Indication | Aplastic anemia [ICD-11: 3A70; ICD-10: D61; ICD-9: 284] | Approved | [1] | |
| Therapeutic Class |
Immunomodulatory Agents
|
|||
| Company |
Pfizer Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | T-cell surface glycoprotein CD1a (CD1A) | Target Info | Binder | [2] |
| KEGG Pathway | Hematopoietic cell lineage | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Approval information for Divalproex Sodium (approved in 1996). 1996. | |||
| REF 2 | Acute sensory neuropathy associated with rabbit antithymocyte globulin. Am J Transplant. 2007 Feb;7(2):484-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.